Health TidingsClywedog’s balomenib Shows Sustained HbA1c Reduction in Type 2 Diabetes Clywedog’s balomenib Shows Sustained HbA1c Reduction in Type 2 Diabetes Read Post »
Clinical TrialsC4 Therapeutics Reports Biomarker Findings from Cemsidomide Studies in Mult... C4 Therapeutics Reports Biomarker Findings from Cemsidomide Studies in Mult... Read Post »
Clinical TrialsTREMFYA Improves Axial Psoriatic Arthritis Symptoms: STAR Study Results TREMFYA Improves Axial Psoriatic Arthritis Symptoms: STAR Study Results Read Post »
Clinical TrialsSura-vec Shows Three-Year DRSS Improvement in Diabetic Retinopathy Sura-vec Shows Three-Year DRSS Improvement in Diabetic Retinopathy Read Post »
Health TidingsGossamer Bio Files First NDA for Seralutinib in Pulmonary Arterial Hyperten... Gossamer Bio Files First NDA for Seralutinib in Pulmonary Arterial Hyperten... Read Post »
Clinical TrialsGefurulimab Shows Sustained 52-Week Disease Control in Phase 3 PREVAIL Tria... Gefurulimab Shows Sustained 52-Week Disease Control in Phase 3 PREVAIL Tria... Read Post »
Health TidingsImfinzi Plus Enfortumab Vedotin Gets FDA Priority Review in Cisplatin-Ineli... Imfinzi Plus Enfortumab Vedotin Gets FDA Priority Review in Cisplatin-Ineli... Read Post »
Health Tidings Mergers & AcquisitionsHenlius, Amberstone Develop Tumor-Activated TCEs for Solid Tumors Henlius, Amberstone Develop Tumor-Activated TCEs for Solid Tumors Read Post »
Health Tidings Mergers & AcquisitionsAtavistik Bio, Roche Partner on Allosteric CVRM Drugs Atavistik Bio, Roche Partner on Allosteric CVRM Drugs Read Post »
New Drug ApprovalFDA Approves Belzutifan Plus Lenvatinib for Advanced RCC With a Clear Cell ... FDA Approves Belzutifan Plus Lenvatinib for Advanced RCC With a Clear Cell ... Read Post »
Clinical TrialsCSPC’s Becotatug Plus Osimertinib Shows Positive Results in EGFR Exon 20 ... CSPC’s Becotatug Plus Osimertinib Shows Positive Results in EGFR Exon 20 ... Read Post »
Clinical TrialsKyverna Reports One-Year Data for Miv-cel in Stiff Person Syndrome and Gene... Kyverna Reports One-Year Data for Miv-cel in Stiff Person Syndrome and Gene... Read Post »
Health TidingsRemlifanserin Phase 2 Trial Narrowly Misses Primary Endpoint in Alzheimers ... Remlifanserin Phase 2 Trial Narrowly Misses Primary Endpoint in Alzheimers ... Read Post »
Health TidingsMerck’s Remigromig Meets Non-Inferiority Endpoint in Phase 2b/3 DME Trial Merck’s Remigromig Meets Non-Inferiority Endpoint in Phase 2b/3 DME Trial Read Post »
Health TidingsAbsci Reports Positive Interim Phase 1 Safety and PK Data for ABS-201 in An... Absci Reports Positive Interim Phase 1 Safety and PK Data for ABS-201 in An... Read Post »
Clinical TrialsIMUNON IMNN-001 Shows 14.7-Month Survival Gain in Ovarian Cancer IMUNON IMNN-001 Shows 14.7-Month Survival Gain in Ovarian Cancer Read Post »
New Drug ApprovalLilly Wins FDA Approval for Once-Weekly Basal Insulin Onswik in Type 2 Diab... Lilly Wins FDA Approval for Once-Weekly Basal Insulin Onswik in Type 2 Diab... Read Post »
Clinical TrialsTECVAYLI Plus DARZALEX FASPRO Shows Sustained Survival Benefit in Early-Lin... TECVAYLI Plus DARZALEX FASPRO Shows Sustained Survival Benefit in Early-Lin... Read Post »
Clinical TrialsPDS0101 Plus Pembrolizumab Shows 39.3-Month Median Overall Survival in HPV1... PDS0101 Plus Pembrolizumab Shows 39.3-Month Median Overall Survival in HPV1... Read Post »
Health TidingsKasvu Raises €30 Million to Advance TrkB Neuroplastogen KTX-0141 Into Cli... Kasvu Raises €30 Million to Advance TrkB Neuroplastogen KTX-0141 Into Cli... Read Post »
Health TidingsMHRA Approves Lurbinectedin Plus Atezolizumab for Extensive-Stage Small Cel... MHRA Approves Lurbinectedin Plus Atezolizumab for Extensive-Stage Small Cel... Read Post »
Health TidingsArcturus Reports Interim Phase 2 OTC Data for ARCT-810, Advances LUNAR 2.0 Arcturus Reports Interim Phase 2 OTC Data for ARCT-810, Advances LUNAR 2.0 Read Post »
Clinical TrialsRoche’s Sefaxersen Cuts Proteinuria in Phase III IgA Nephropathy Study Roche’s Sefaxersen Cuts Proteinuria in Phase III IgA Nephropathy Study Read Post »
Drugs Safety AlertFDA Approves Boxed Warning for Adzynma Over Antibody Risk FDA Approves Boxed Warning for Adzynma Over Antibody Risk Read Post »
New Drug ApprovalFDA Approves Lyrfigtu for FGFR2-Positive Cholangiocarcinoma FDA Approves Lyrfigtu for FGFR2-Positive Cholangiocarcinoma Read Post »
Clinical TrialsORKA-001 Sustains Deep Psoriasis Clearance Through Week 28 After Two Doses ORKA-001 Sustains Deep Psoriasis Clearance Through Week 28 After Two Doses Read Post »
Clinical TrialsImmunovant Ends IMVT-1402 Development in Cutaneous Lupus After CLE Study Mi... Immunovant Ends IMVT-1402 Development in Cutaneous Lupus After CLE Study Mi... Read Post »
Health TidingsViferaXS Raises €12 Million to Advance CLLTAXS01 Into Phase II in CLL ViferaXS Raises €12 Million to Advance CLLTAXS01 Into Phase II in CLL Read Post »
Health TidingsFDA Updates WINREVAIR Label with HYPERION Data in Newly Diagnosed PAH FDA Updates WINREVAIR Label with HYPERION Data in Newly Diagnosed PAH Read Post »
Health TidingsACI-7104 Shows 100% Antibody Response in Phase 2 Parkinson’s Disease Tria... ACI-7104 Shows 100% Antibody Response in Phase 2 Parkinson’s Disease Tria... Read Post »
Health TidingsCBL-514 Reduces Dercum’s Disease Pain in Phase 2 Trial, Supporting Lipede... CBL-514 Reduces Dercum’s Disease Pain in Phase 2 Trial, Supporting Lipede... Read Post »
Health TidingsCelldex’s Barzolvolimab Hits Phase 3 Endpoints in Chronic Spontaneous Urt... Celldex’s Barzolvolimab Hits Phase 3 Endpoints in Chronic Spontaneous Urt... Read Post »
Clinical TrialsVarespladib Misses Phase 2 BRAVIO Primary Endpoints but Shows Signals in Kr... Varespladib Misses Phase 2 BRAVIO Primary Endpoints but Shows Signals in Kr... Read Post »
Clinical TrialsTegoprubart Shows Promising 24-Month Kidney Function Advantage Over Tacroli... Tegoprubart Shows Promising 24-Month Kidney Function Advantage Over Tacroli... Read Post »
Health TidingsFDA Lifts Clinical Hold on Filana’s Simufilam IND for TSC-Related Epileps... FDA Lifts Clinical Hold on Filana’s Simufilam IND for TSC-Related Epileps... Read Post »
Clinical TrialsViking’s VK2735 Maintains Most Weight Loss with Less Frequent Dosing Viking’s VK2735 Maintains Most Weight Loss with Less Frequent Dosing Read Post »
Clinical TrialsAmgen’s Dazodalibep Meets Phase 3 Endpoint in Sjögren’s Disease Amgen’s Dazodalibep Meets Phase 3 Endpoint in Sjögren’s Disease Read Post »
Health Tidings Mergers & AcquisitionsLexeo Expands Friedreich Ataxia Pipeline With Mantle Acquisition Lexeo Expands Friedreich Ataxia Pipeline With Mantle Acquisition Read Post »
Health Tidings Mergers & AcquisitionsEnvisagenics, Boehringer Partner on RNA Splicing Cancer Targets Envisagenics, Boehringer Partner on RNA Splicing Cancer Targets Read Post »
Clinical TrialsOtsuka Reports Positive Phase 3 FUSION Results in FUS-ALS Otsuka Reports Positive Phase 3 FUSION Results in FUS-ALS Read Post »
Clinical TrialsInaxaplin Reduces Proteinuria in Phase 2b AMPLIFIED AMKD Trial Inaxaplin Reduces Proteinuria in Phase 2b AMPLIFIED AMKD Trial Read Post »
Clinical TrialsFasedienol Shows Progressive Improvement in Social Anxiety During PALISADE-... Fasedienol Shows Progressive Improvement in Social Anxiety During PALISADE-... Read Post »
Health TidingsFDA Recommends Overall Survival Trial Prior to BLA Submission for Tovecimig... FDA Recommends Overall Survival Trial Prior to BLA Submission for Tovecimig... Read Post »
Clinical TrialsElunetirom Shows Positive Phase 2 Results in Bipolar Depression Elunetirom Shows Positive Phase 2 Results in Bipolar Depression Read Post »
Health TidingsIvonescimab Beats Durvalumab on OS in Phase III Trial Ivonescimab Beats Durvalumab on OS in Phase III Trial Read Post »
Health TidingsPharming’s Leniolisib Shows Encouraging Results in Phase II PID Trial Pharming’s Leniolisib Shows Encouraging Results in Phase II PID Trial Read Post »
Clinical TrialsRoche’s Enicepatide Shows Positive Results in Phase II T2D Trial Roche’s Enicepatide Shows Positive Results in Phase II T2D Trial Read Post »
New Drug ApprovalRINVOQ Gains EU Approval for Pediatric Polyarticular JIA RINVOQ Gains EU Approval for Pediatric Polyarticular JIA Read Post »
New Drug ApprovalRoche Susvimo Wins EU Approval for Neovascular AMD Roche Susvimo Wins EU Approval for Neovascular AMD Read Post »
Health Tidings Mergers & AcquisitionsAbbVie and Iambic Partner to Accelerate AI-Driven Small-Molecule Drug Disco... AbbVie and Iambic Partner to Accelerate AI-Driven Small-Molecule Drug Disco... Read Post »
